A novel mutation (Thr116IIe) in the presenilin 1 gene in a patient with early-onset Alzheimer's disease

European Journal of Neurology

Volumn 11, Issue 8, 2004, Pages 521-524

  La Bella, V ^a,d   Liguori, M ^b   Cittadella, R ^b   Settipani, N ^a   Piccoli, T ^a   Manna, I ^b   Quattrone, A ^b,c   Piccoli, F ^a  

^a UNIVERSITY OF PALERMO   (Italy)

^b INSTITUTE OF NEUROLOGICAL SCIENCES   (Italy)

^c UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^d Institute of Neuropsychiatry   (Italy)

Author keywords

Alzheimer's Disease; Novel mutation; Presenilin 1

Indexed keywords

PRESENILIN 1; ISOLEUCINE; MEMBRANE PROTEIN; PSEN1 PROTEIN, HUMAN; THREONINE;

ADULT; ALZHEIMER DISEASE; AMNESIA; ANAMNESIS; ARTICLE; CASE REPORT; CONFUSION; CONTROLLED STUDY; DISEASE CARRIER; DISEASE COURSE; DISORIENTATION; DNA POLYMORPHISM; FAMILY HISTORY; FEMALE; GENE MUTATION; HETEROZYGOTE; HUMAN; MEMORY DISORDER; NEUROIMAGING; NEUROPATHOLOGY; ONSET AGE; PEDIGREE; PRIORITY JOURNAL; RELATIVE; GENETICS; METHODOLOGY; MIDDLE AGED; MUTATION; NUCLEOTIDE SEQUENCE;

ALZHEIMER DISEASE; DNA MUTATIONAL ANALYSIS; FEMALE; HUMANS; ISOLEUCINE; MEMBRANE PROTEINS; MIDDLE AGED; MUTATION; PRESENILIN-1; THREONINE;

EID: 4043089149     PISSN: 13515101     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2004.00828.x     Document Type: Article

References (15)

1. Arduengo PM, Appleberry OK, Chuang P, L'Hemault SW (1998). The presenilin protein family member SPE-4 localizes to an ER/Golgi derived organelle and is required for proper cytoplasmic partitioning during Caenorhabditis elegans spermatogenesis. J Cell Sci 111:3645-3654.
2. Cruts M, Van Broeckhoven C (1998). Molecular genetics of Alzheimer's disease. Ann Med 30:560-565.
3. Cruts M, van Duijn CM, Backhovens H et al. (1998). Estimation of the genetic contribution of presenilin-1 and -2 mutations in a population-based study of presenile Alzheimer disease. Hum Mol Genet 7:43-51.
4. Lippa CF (1999). Familial Alzheimer's disease: genetic influences on the disease process. Int J Mol Med 4:529-536.
5. Lippa CF, Swearer JM, Kane KJ et al. (2000). Familial Alzheimer's disease: site of mutation influences clinical phenotype. Ann Neurol 48:376-379.
6. Mazzei R, Conforti FL, Muglia M et al. (2003). A simple method for diagnosis of autosomal recessive spinal muscular atrophy by denaturing high-performance liquid chromatography. J Child Neurol 18:269-271.
7. Pasternak SH, Bagshaw RD, Guiral M et al. (2003): Presenilin, Nicastrin and Beta-Amyloid Production in the endosomal/lysosomal system: toward a unifying model of Alzheimer's disease. J Biol Chem May 6 [Epub ahead of print]. PMID: 12734203.
8. Price DL, Sisodia SS (1998). Mutant genes in familial Alzheimer's disease and transgenic models. Annu Rev Neurosci 21:479-505.
9. Rogaeva EA, Fafel KC, Song YQ et al. (2001). Screening for PS1 mutations in a referral-based series of AD cases. 21 novel mutations. Neurology 57:621-625.
10. Romero I, Jorgensen P, Bolwig G et al. (1999). A presenilin-1 Thr116Asn substitution in a family with early-onset Alzheimer's disease. Neuroreport 10:2255-2258.
11. Siman R, Velji J (2003). Localization of presenilin-nicastrin complexes and gamma-secretase activity to the trans-Golgi network. J Neurochem 84:1143-1153.
12. Tandon A, Fraser P (2002). The presenilins. Genome Biology 3:3014.1-3014.9.
13. The Human Gene Mutation Database Cardiff (2003). Presenilin 1 mutations (missense/ nonsense) http://archive.uwcm.ac.uk/uwcm/mg/ns/1/135682.htlm.
14. Van Gassen G, Annaert W (2003). Amyloid, presenilins, and Alzheimer's disease. Neuroscientist 9:117-126.
15. Wisniewski T, Dowiat WK, Buxbaum JD et al. (1998). A novel Polish presenilin-1 mutation (P117L) is associated with familial Alzheimer's disease and leads to death as early as the age of 28 years. Neuroreport 9:217-221.